ELUT

HighCape Capital, LLC

Known title: 10% OwnerCIK: 0001827500

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

Elutia Secures $8M from Boston Scientific, Funds Through 2029. Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.

this person other insiders at ELUT

Transaction History

ELUT▼ Sell$3.0M
ELUT▼ Sell—
ELUT▲ Buy—

We use analytics to understand how market-wall is used. No personal data is sold.